Point of Care Tests in the Management of Very Early Medical Abortion

Condition(s) studied

Investigational drug(s) / intervention(s)

Blood test: Patients will undergo one additional blood test than is usual with standard care, to measure Human Chorionic Gonadotropin (HCG) level which will be analysed on a point of care test machine and in the lab

Participant Questionnaire: The investigators will administer participant questionnaires to both staff and patients to understand opinions on the point of care test machine

Study summary

This study will investigate the use of a point of care test in patients who are having an abortion at a gestation of \<6 weeks (known as a very early medical abortion). These patients have pregnancy hormone level checked at Day 0 and Day 7 to see if treatment has worked. The investigators plan to use a point of care test machine to see if it is possible to check pregnancy hormone level earlier than Day 7.

Eligibility

Primary outcome measure(s)

• Sensitivity — Day 0, Day 2-4 and Day 7
  Sensitivity of percentage change in Human Chorionic Gonadotropin (HCG) between Day 0 and Day2-4 compared with percentage change in Human Chorionic Gonadotropin (HCG) between Day 0 and Day 7
• Specificity — 7 days
  The Specificity of percentage HCG drop between Day 0 and Day 2-4, compared with specificity of percentage HCG drop between Day 0 and Day 7

Trial sites (3)